Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Zomedica Corp. Common Shares (NY:ZOM)

0.0973 UNCHANGED
Last Price Updated: 8:00 PM EST, Mar 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Zomedica Corp. Common Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Zomedica to Report First Quarter 2024 Financial Results and Provide Business Update on May 9th at 4:30 p.m. ET
Via ACCESSWIRE
Zomedica to Present at the Noble Capital Markets Virtual Healthcare Conference on April 17, 2024
Via ACCESSWIRE
ZOM Stock Earnings: Zomedica Beats Revenue for Q4 2023
ZOM stock results show that Zomedica beat on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Zomedica Reports Record Revenue of $7.3 Million for the Fourth Quarter and $25.2 Million for the Full Year 2023, Reflecting 33% Annual Growth; 69% Gross Margin and $100.5 Million in Liquidity
Via ACCESSWIRE
Zomedica to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Monday, April 1, 2024, at 4:30 p.m. ET
Via ACCESSWIRE
Earnings Scheduled For April 1, 2024
Companies Reporting Before The Bell • Mach Natural Resources (NYSE:MNR) is projected to report quarterly earnings at $0.92 per share on revenue of $213.43 million. 
Via Benzinga
Zomedica Announces Publication of Research Concluding TRUFORMA(R) Platform is More Accurate Diagnostic Test for Feline Hyperthyroidism than Chemiluminescent Immunoassay (CLIA) Platform
Via ACCESSWIRE
Zomedica Provides NYSE American Listing Update
Via ACCESSWIRE
Zomedica Announces Sponsorship of Educational Presentations at Fetch dvm360 Veterinary Conferences
Via ACCESSWIRE
Zomedica Announces Publication of Case Series Highlighting Success with PulseVet(R) Shock Wave Therapy for Difficult to Treat Fibrotic Myopathy in Working Dogs
Via ACCESSWIRE
Zomedica to Present at the Sidoti Small Cap Conference March 14, 2024
Via ACCESSWIRE
3 High-Reward Penny Stocks to Uncover Big Gains
Dive into the realm of high-reward penny stocks. The article gives the insights you need to spot quality plays and make informed decisions. 
Via InvestorPlace
Zomedica Announces Sponsorship of Educational Presentations at Major Veterinary Health Conferences
Via ACCESSWIRE
7 Penny Stocks to Buy on the Dip: February 2024
With the markets turning lower, these penny stocks to buy stand out as attractive options. Consider these seven stocks. 
Via InvestorPlace
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Zomedica Shareholders Vote for the Share Consolidation (Reverse Stock Split)
Via ACCESSWIRE
Zomedica to Host Virtual Investor Day February 13 at 3:00 p.m. ET
Via ACCESSWIRE
3 Hidden-Gem Penny Stocks That Could Yield Life-Changing Wealth
Unlock the secret to wealth with insights on ZOM, SNDL, and BLDE. Discover how these penny stocks could redefine your future. 
Via InvestorPlace
Open Letter to Zomedica Shareholders from your Chief Executive Officer
Via ACCESSWIRE
Zomedica to Participate in the Lytham Partners 2024 Investor Select Conference
Via ACCESSWIRE
Leading Proxy Advisory Firm ISS Recommends Zomedica Shareholders Vote "FOR" Proposed Reverse Stock Split
Via ACCESSWIRE
Zomedica Announces Preliminary 2023 Revenue; Provides Revenue Guidance for 2024, and Rationale for Share Consolidation ("Reverse Stock Split")
Via ACCESSWIRE
3 Breakout Penny Stocks Primed for Massive Gains
Discover three penny stocks poised for breakout success in veterinary, liquor retail, and insurance sectors. 
Via InvestorPlace
Zomedica Corp. to Host Conference Call on January 17, 2024, at 4:30 p.m. ET to Provide a Business Update, Preliminary 2023 Revenue and Cash Position, and Discuss the Proposed Reverse Stock Split; Provides Notice of Special Virtual-Only Meeting of
Via ACCESSWIRE
Budget Bets: Top 3 Penny Stocks with Potential for Explosive Growth
These cheap stocks offer investors an extreme risk to reward tradeoff, which might be worth considering for lucrative payoffs. 
Via InvestorPlace
Zomedica Announces Publication of Research Validating Better Patient Acceptance of PulseVet(R) Electro-hydraulic Shock Wave Therapy without Sedation Utilizing Novel “X-Trode” Handpiece
Via ACCESSWIRE
Zomedica Announces Expansion of Market Opportunity for TRUFORMA(R) Diagnostic Platform with Launch of Three New Assays for Commonly Performed Diagnostic Tests for Canine Gastrointestinal Disease
Via ACCESSWIRE
Zomedica Announces Presentation of Clinical Data in Support of New Indications for PulseVet Shock Wave Therapy at Annual Meeting of American Association of Equine Practitioners
Via ACCESSWIRE
Zomedica to Present at Noble Capital Markets' 19th Annual Emerging Growth Equity Conference
Via ACCESSWIRE
Zomedica to Present at the 35th Annual Piper Sandler Healthcare Conference
Via ACCESSWIRE
Zomedica Announces Record Third Quarter 2023 Financial Results: Revenue up 31% to $6.3 Million; 69% Gross Margin, and $118 Million in Liquidity, while Making Strategic Acquisitions of Structured Monitoring Products and Qorvo Biotechnologies
Via ACCESSWIRE
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback